Immunotherapy combo shows promise in Tough-to-Treat breast cancer

NCT ID NCT04085276

First seen Apr 26, 2026 · Last updated May 12, 2026 · Updated 2 times

Summary

This study tested whether adding the immunotherapy drug toripalimab to standard chemotherapy (nab-paclitaxel) helps people with metastatic or recurrent triple-negative breast cancer live longer without their cancer growing. About 531 participants received either the combination or a placebo plus chemo. The goal was to see if the immune-boosting drug could better control the disease in this aggressive cancer type.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Chengde Medical University

    Chengde, China

  • Affiliated Hospital of Hebei University

    Baoding, China

  • Affiliated Hospital of Jiangnan University(Wuxi NO.4 People's Hospital)

    Wuxi, China

  • Anhui Province Hospital & The First Affiliated Hospital of USTC

    Hefei, China

  • Beijing Hospital

    Beijing, Beijing Municipality, China

  • Cancer Hospital Affiliated to Xinjiang Medical University

    Ürümqi, China

  • Changhai Hospital

    Shanghai, China

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China

  • Chongqing Cancer Hospital

    Chongqing, China

  • Fujian Medical University Union Hospital

    Fuzhou, China

  • General Hospital of Ningxia Medical University

    Yinchuan, China

  • Guangdong General Hospital

    Guangzhou, China

  • Harbin Medical University Cancer Hospital

    Harbin, China

  • Henan Cancer Hospital

    Zhengzhou, China

  • Henan Provincial People's Hospital

    Zheng'zhou, China

  • Hubei Cancer Hospital

    Wuhan, China

  • Hunan Cancer Hospital

    Changsha, China

  • Jiangsu Cancer Hospital

    Nanjing, China

  • Jiangsu Province Hospital

    Nanjing, China

  • Jiangxi Cancer Hospital

    Nanchang, China

  • Jilin Cancer Hospital

    Changchun, China

  • Liaoning Cancer Hospital&Intitute

    Shenyang, China

  • Linyi Cancer Hospital

    Linyi, China

  • Peking University Shougang Hospital

    Beijing, Beijing Municipality, China

  • Shandong Cancer Hospital

    Jinan, China

  • Shanghai General Hospital

    Shanghai, China

  • Sichuan Cancer Hospital

    Chengdu, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, China

  • The Affiliated Hospita of Inner Mongolia Medical University

    Hohhot, China

  • The Affiliated Hospita of of Southwest Medical University

    Luzhou, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, China

  • The Fifth Medical Center of PLA General Hospital

    Beijing, Beijing Municipality, 100071, China

  • The First Affiliated Hospital Zhejiang University

    Hangzhou, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China

  • The First Affiliated Hospital of Xiamen University

    Xiamen, China

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China

  • The First Hospital of China Medical University

    Shenyang, China

  • The First Hospital of Jilin University

    Changchun, China

  • The First People's Hospital of Foshan

    Foshan, China

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, China

  • The Second Affiliated Hospital of The PLA Air Force Military Medical University

    Xi'an, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • The Second Hospital of Anhui Medical University

    Hefei, China

  • The Second Hospital of Dalian Medical University

    Dalian, China

  • The Third Hospital of Nanchang

    Nanchang, China

  • The Women and Children's Hospital of Guangdong Province

    Guangzhou, China

  • The first affiliated Hospital of Bengbu Medical College

    Bengbu, China

  • Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, China

  • Xiangyang Central Hospital

    Xiangyang, China

  • Yunnan Cancer Hospital

    Kunming, China

  • Zhejiang Cancer Hospital

    Hangzhou, China

Conditions

Explore the condition pages connected to this study.